Abstract
The present study was undertaken in order to establish whether oxytocin (OT) affects the dopaminergic control of PRL secretion in normal women during follicular, periovulatory and luteal phase of their menstrual cycle. For this purpose, 22 normal women were tested with a lower (1 mg) or higher (10 mg) dose of the dopaminergic antagonist metoclopramide (MCP) with or without the concurrent treatment with OT (2 IU injected plus 0.033 IU/min infused for 2 h). Since OT was found unable to modify the effect of either 1 or 10 mg MCP, in additional experiments the same doses of MCP and OT were administered after dopamine (0.04 µg/kg/min for 2 h) infusion. Also in these experimental conditions OT failed to modify the PRL response to MCP. These data argue against a role of OT in modulation of the dopaminergic control of PRL secretion in normal women.
Similar content being viewed by others
References
Baylis P.H. Posterior pituitary in health and disease. Clin. Endocrinol. Metab. 12: 747, 1983.
Vandesand F., Dierickx K. Identification of the vasopressin producing and of the oxytocin producing neurons in the hypothalamic magnocellular neurosecretory system of the rat. Cell. Tissue Res. 164: 153, 1975.
Horn A.M., Robinson A.F., Fink G. Oxytocin and vasopressin in rat hypophysial portal blood: experimental studies in normal Brattleboro rats. J. Endocrinol. 104: 211, 1985.
Gibbs D.M. High concentrations of oxytocin in hypophysial portal plasma. Endocrinology 114: 1216, 1984.
Page S.R., Ang V.T.Y., Jackson R., White A., Nussey S.S., Jenkins J.S. The effect of oxytocin infusion on adenohypophyseal function in man. Clin. Endocrinol (Oxf.) 32: 307, 1990.
Nussey S.S., Page S.R., Ang V.T.Y., Jenskins J.S. The effect of oxytocin infusion on adenohypophyseal and adrenal cortical responses to insulin-induced hypoglycaemia. Clin. Endocrinol. (Oxf.) 29: 257, 1988.
Coiro V., Passeri M., Davoli C., Bacchi-Modena A., Bianconi L., Volpi R., Chiodera P. Oxytocin reduces-induced ACTH and cortisol rise in man. Acta Endocrinol. (Copenh.) 119: 405, 1988.
Lumpkin M.D., Samson W.K., McCann S.M. Hypothalamic and pituitary sites of action of oxytocin to alter prolactin secretion in the rat. Endocrinology 112: 1711, 1983.
Samson W.K., Lumpkin M.D., McCann S.M. Evidence for a physiological role for oxytocin in the control of prolactin secretion. Endocrinology 119: 554, 1986.
Johnston C.A., Negro Vilar A. Role of oxytocin on prolactin secretion during proestrous in different physiological or pharmacological paradigms. Endocrinology 122: 341, 1986.
Coiro V., Gnudi A., Volpi R., Marchesi C., Salati G., Caffarra P., Chiodera P. Oxytocin enhances thyrotropin releasing hormone induced prolactin release in normal menstruating women. Fertil. Steril. 47: 565, 1987.
Delitala G., Masala A., Alagna S., Devilla L. Effect of metoclopramide on serum prolactin levels in human. Clin. Endocrinol. (Oxf.) 5: 731, 1976.
McCallum R.W., Sower J.R., Hershman J.M., Sturdevant R.A.L. Metoclopramide stimulates prolactin secretion in man. J. Clin. Endocrinol. Metab. 42: 1148, 1976.
Kitaoka M., Takebe K., Kobayashi M., Nakazono M., Kudo M. Dose-dependency and reproducibility of prolactin response to metoclopramide. Horm. Metab. Res. 12: 155, 1980.
Agner T., Hagen C., Andersen A.N., Djursing H. Increased dopaminergic activity inhibits basal and metoclopramide-stimulated prolactin and thyrotropin secretion. J. Clin. Endocrinol. Metab. 62: 778, 1986.
Sinha Y.N., Selby F.W., Lewis U.J., van der Laan W.P. A homologous radioimmunoassay for human prolactin. J. Clin. Endocrinol. Metab. 36: 509, 1973.
de Hertog R., Thomas K., Bietlot Y., Vanderheyden I., Ferin J. Plasma levels of unconjugated estrone, estradiol and estriol and HCS throughout pregnancy in normal women. J. Clin. Endocrinol. Metab. 40: 93, 1975.
de Villa O., Roberts K., Wiest W.G., Mikhail G., Flickinger G. A specific radioimmunoassay of plasma progesterone. J. Clin. Endocrinol. Metab. 35: 458, 1972.
Tashjian Jr A.H., Barowsky N.J., Jensen D.K. Thyrotropin-releasing hormone: direct evidence for stimulation of prolactin production by pituitary cells in culture. Biochem. Biophys. Res. Commun. 43: 516, 1971.
Gershengorn M.C. Mechanism of thyrotropin-releasing hormone stimulation of pituitary hormone secretion. Am. Rev. Physiol. 48: 515, 1986.
de Greef W.J., Visser T.J. Evidence for the involvement of hypothalamic dopaminic and thyrotropin-releasing hormone in suckling-induced release of prolactin. J. Endocrinol. 91: 213, 1981.
Mena F., Clapp C., Aguayo D., Martinez-Escalera G. Differential effects of thyrotropin-releasing hormone on in vitro release of in vivo or in vitro newley synthesized and mature prolactin by lactating rat adenohypophyses: further evidence for a sequential pattern of hormone release. Neuroendocrinology 49: 207, 1989.
Mena F., Clapp C., Aguayo D., Morales M.T., Grosvenor C.E., Martinez de la Escalera G. Regulation of prolactin secretion by dopamine and thyrotropin-releasing hormone in lactating rat adenohypophyses: influence of intracellular age of the hormone. Endocrinology 125: 1814, 1989.
MacLeod R.M., Lehmeyer J.E. Studies on the mechanism of the dopamine-mediated inhibition of prolactin secretion. Endocrinology 94: 1077, 1974.
Cheung C.Y., Kuhn R.W., Weiner R.I. Increased responsiveness of the dopamine-mediated inhibition of prolactin synthesis after destruction of the medial basal hypothalamus. Endocrinology 108: 747, 1981.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Chiodera, P., Volpi, R., Gramellini, D. et al. Oxytocin does not modify the prolactin response to metoclopramide in normal women. J Endocrinol Invest 14, 463–468 (1991). https://doi.org/10.1007/BF03346844
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03346844